Trial of syphilis pre-exposure prophylaxis opens to enrollment

The study team screened its first participant for the DaDHS trial of doxycycline as pre-exposure prophylaxis against syphilis and other bacterial sexually transmitted infections today.  Congratulations to study coordinator Reva Persaud for launching the trial!  Read more about the trial here.